Test Price
170 AED✅ Home Collection Available
Herpes Simplex Virus (HSV) 1 Antibodies Panel IgG & IgM, Serum in UAE | 170 AED | DHA Licensed
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing using advanced Chemiluminescent Immunoassay (CLIA).
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM. Same-day result processing for samples collected by 9 AM (Sunday–Thursday).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance provided by our DHA-licensed General Practitioner for result interpretation.
- Insurance & Billing: Direct Billing Verification via WhatsApp +971 54 548 8731. Cash, card, and insurance accepted.
- Regulatory Compliance: Fully compliant with UAE Federal Decree-Law No. 45 of 2021 (PDPL) and Federal Law No. 2 of 2019.
Test Overview & Methodology
The Herpes Simplex Virus Type 1 (HSV-1) Antibody Panel quantifies both IgG (past/latent infection marker) and IgM (recent/active infection marker) antibodies in serum. This differentiated serological profile enables precise infection staging—distinguishing primary infection, reactivation, and past exposure with established immunity. The panel employs high-throughput Chemiluminescent Immunoassay (CLIA) technology, delivering 99.9% diagnostic sensitivity and specificity for confident clinical decision-making.
| Feature | Our UAE Accredited Lab (DNA Labs UAE) | Standard Clinic Alternative |
|---|---|---|
| Methodology | Chemiluminescent Immunoassay (CLIA) – high throughput, ultra-sensitive, fully automated | Conventional ELISA (often manual, lower throughput) |
| Diagnostic Sensitivity | 99.9% (validated against international reference standards) | 94–96% |
| Turnaround Time | Same day (sample collected by 9 AM Sunday–Thursday) | 2–4 business days |
| Home Collection | VIP Mobile Phlebotomy with cold-chain transport, daily 8 AM–11 PM | Usually not available; must visit clinic |
Physician Insight & Safety Protocols
“HSV-1 antibody results must always be interpreted in the full context of your symptoms and clinical history. A positive IgM can indicate recent infection but may occasionally persist or show cross-reactivity; a positive IgG alone confirms past exposure with established immunity. This panel is a powerful tool for differentiating primary infection from recurrence, but a comprehensive clinical correlation by your treating physician remains essential for accurate management. I strongly recommend discussing all results with your doctor before making any treatment decisions.”
— Dr. Ajay Singh, General Practitioner | DHA Registration ID: 36234132
Patient Advisory: Medication & Clinical Context
⚠️ Important Clinical Advisory
Do not discontinue, adjust, or initiate any prescribed medication—including antiviral therapy—without consulting your treating physician. Antiviral treatment decisions must be guided by a complete clinical evaluation, including symptom assessment, physical examination, and laboratory results. Self-medication can lead to resistance or adverse effects.
Exclusion Criteria & Emergency Red Flags
- Exclusion Criteria: Severe immunocompromised state (e.g., recent chemotherapy, organ transplant, high-dose corticosteroids); blood transfusion or blood product administration within the last 3 months (may interfere with antibody detection).
- Emergency Red Flags – Seek Immediate Medical Attention: High fever (>38.5°C) accompanied by painful oral or genital ulcers; confusion, severe headache, stiff neck, or photophobia (may indicate herpes encephalitis); widespread vesicular rash in an immunocompromised patient.
Patient FAQ & Clinical Guidance
1. What does a positive HSV-1 IgG and negative IgM result indicate?
A positive HSV-1 IgG with a negative IgM typically signifies a past infection with established immunity, not an active new outbreak. This serological pattern is common in the majority of adults worldwide and does not require immediate antiviral therapy unless new lesions or symptoms appear. Always discuss your results with your healthcare provider for a personalized management plan.
2. How soon after exposure can this panel detect HSV-1 infection?
Our CLIA-based HSV-1 antibody panel detects IgM antibodies approximately 7 to 10 days following exposure, while IgG antibodies become detectable after 3 to 4 weeks. For acute symptomatic cases—especially when active lesions are present—a PCR swab of the lesion is recommended alongside serology for maximum diagnostic accuracy. A negative early IgM result does not rule out recent infection.
3. Is fasting or special preparation required before the blood draw?
No special preparation or fasting is required. A simple blood draw of 3 mL serum in an SST tube is sufficient. You may continue all regular medications, meals, and daily activities. Our trained phlebotomist will collect the sample at your preferred location and ensure cold-chain transport to our ISO-accredited laboratory for processing.
4. Can this test distinguish between HSV-1 and HSV-2 infection?
This panel specifically detects antibodies against HSV-1 only. For differentiation between HSV-1 and HSV-2 infection, a type-specific serology panel (HSV-1 and HSV-2 IgG/IgM combined) is recommended. Our laboratory offers a comprehensive herpes serology panel upon request. Discuss with your physician which test is appropriate for your clinical situation.
5. How are my test results delivered and interpreted?
Results are delivered electronically via secure email and WhatsApp within the same day of collection. Our DHA-licensed General Practitioner provides telephonic post-test clinical guidance to help you understand your results. A comprehensive interpretive report including reference ranges and clinical recommendations is included. We recommend a follow-up consultation with your treating physician for integrated care.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance & Trust Framework
DNA Labs UAE operates under the regulatory oversight of the Dubai Health Authority (DHA) and adheres to the highest standards of data protection and clinical safety. All patient data is handled in full compliance with:
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) – ensuring your health information is collected, processed, and stored with strict confidentiality and security controls.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields – governing the secure handling of electronic health records and telemedicine services.
- Federal Decree-Law No. 4 of 2016 on Medical Liability – establishing the legal framework for clinical safety, informed consent, and patient rights throughout the diagnostic process.
All laboratory procedures are ISO 9001:2015 accredited (Cert: INT/EGQ/2509DA/3139). Your trust and safety are our highest priorities.
Clinical & Logistical Metadata
| Test Name | Herpes Simplex Virus (HSV) 1 Antibodies Panel IgG & IgM, Serum |
| Price (AED) | 170 AED |
| Turnaround Time | Same day (samples collected by 9 AM Sunday–Thursday) |
| Sample Type / Matrix | Serum (3 mL SST tube). VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily 8 AM–11 PM. |
| Methodology Used | Chemiluminescent Immunoassay (CLIA) |
| ICD-10-CM Code | B00.9 (Herpesviral infection, unspecified) |
| LOINC Code | 20580-7 (HSV-1 IgG), 20578-1 (HSV-1 IgM) |
| DHA Facility License & Laboratory Address | DHA Facility License Number: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians